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Advances in the clinical management of patients with acute and chronic spinal cord injury 
(SCI) have contributed to extended life expectancies; however longevity in those with SCI 
remains below that of the general population.(1) Reduced longevity in the SCI population 
has been attributed to increased incidence of age-associated chronic illnesses,(2) premature 
cardiovascular aging,(3) and increased prevalence of heart disease, stroke (4) and diabetes 
mellitus, (5) compared to the general population. In fact, cardiovascular disease (CVD) is 
now a leading cause of morbidity and mortality in the SCI population, which may be 
amplified due to increased risk factors such as inactivity, chronic inflammation, and 
impairment in autonomic cardiovascular control.(6)
The American Spinal Injury Association (ASIA) impairment scale (AIS) is used to 
document remaining motor and sensory function following SCI; (7, 8) however, the degree 
of autonomic nervous system impairment is not considered within this classification schema.
(9, 10) That said, impaired autonomic control of the cardiovascular system after SCI results 
in measurable changes in heart rate (HR) and blood pressure (BP) that loosely reflect the 
level and completeness of SCI documented using the AIS classification, (11, 12) but may 
also reflect orthostatic positioning.(6, 12, 13) The impact of these changes in HR and BP on 
cardiovascular health and longevity is not fully appreciated in the SCI population; however, 
prior to identifying the consequences of these cardiovascular abnormalities, prevalence rates 
of HR and BP values which fall outside the expected normal range should be documented.
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The International Standards to Document Autonomic Function (post-SCI) initially 
established guidelines for the assessment of HR and BP abnormalities in 2009, (10) which 
was updated in 2012, but the thresholds remained consistent. (14) Specifically, bradycardia 
is defined as a HR ≤ 60 beats/minute (bpm) and tachycardia as a HR ≥ 100 bpm. (14) 
Hypotension is defined as a systolic BP (SBP) ≤ 90 mmHg and a diastolic BP (DBP) ≤ 60 
mmHg; hypertension is SBP ≥ 140 and/or DBP ≥ 90 mmHg. (14) While these definitions 
comply with standards established in the non-SCI population, due to decentralized 
cardiovascular control, they may not be appropriate for use in the SCI population. In 
addition, relatively recent evidence has emerged which associates adverse outcomes in the 
general population using other HR (15, 16) and BP (17-21) thresholds. Beyond the clinical 
consequences of alterations in HR and BP, persons with SCI may experience loss of 
independence and life quality related to the inability to adequately maintain cardiovascular 
homeostasis; however, until we gain a better understanding of the prevalence of these 
abnormalities, the development and testing of effective treatment strategies will not be a 
priority.
Therefore, the goal of this investigation was to assess HR and BP in veterans with (SCI) and 
without SCI (non SCI). Similar to a recent report, (6) we hypothesized that level of SCI (i.e., 
the higher the lesion level the greater the prevalence of abnormal HR and BP recordings) 
and orthostatic positioning (i.e., increased prevalence of abnormal HR and BP recordings in 
the seated versus the supine position) would influence the prevalence of HR and BP 
abnormalities. In addition, we hypothesized that the prevalence of comorbid cardiovascular 
medical conditions, current smoking status, age and use of prescription anti-hypertensive 
(anti-HTN) medications would influence the prevalence of HR and BP abnormalities in 
veterans with and without SCI.
METHODS
Subjects
All investigative procedures were performed at an urban Veterans Affairs Medical Center 
(VAMC) in a convenience sample of veterans with and without SCI. The subjects were not 
matched but were recruited based on willingness to volunteer and having met the inclusion 
criteria. Veterans with and without SCI were approached and asked to participate in the 
study during their annual physical examination or in a waiting room area prior to being seen 
for a routine clinical follow-up appointment. None of the subjects was receiving clinical care 
for an acute illness or infection, which was ascertained via medical history questionnaire and 
verified in the medical record. Prior to initiating data collection procedures, subjects were 
asked questions related to their personal characteristics, which included a complete medical 
history, prescription medication use, and information pertaining to any chronic medical 
conditions, which wasverified via electronic medical chart review and corrected if needed. 
Subjects were then transferred to a clinic bed for instrumentation and a period of quiet rest 
in the supine position prior to data collection. All study procedures were approved by the 
local IRB.
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Resting HR and BP assessments were measured for 5 minutes in the supine position in all 
subjects, for 5 minutes while seated in the veterans with SCI and for 5 minutes while 
standing in the veterans without SCI; data were recorded at minutes 0, 1, 2, 3, 4 & 5 for a 
maximum of six recordings in each position. Recording of HR and BP assessments were 
made using an automated sphygmomanometer BP cuff (Dynamap Pro 300, [GE Healthcare, 
Buckinghamshire, UK]), which was placed around the upper right arm. Data collection 
began in the supine position for all subjects and once complete subjects were either 
transferred to their wheelchair (SCI) or were asked to stand (non-SCI).
Operative Definitions
We examined the incidence of a resting HR ≥ 80 bpm among veterans with and without SCI 
because of the possible association between persistent cardiac acceleration (CA) and 
vascular degeneration and cardiac mortality.(16, 22, 23) An average resting HR above 80 
bpm in either the supine or upright positions was used to classify individuals with potential 
CA. Systolic hypotension (HYPO) was defined according to the World Health Organization 
(W.H.O.) as a systolic BP (SBP) ≤ 110 mmHg for males and ≤ 100 mmHg for females.(24) 
The W.H.O. definition of hypotension is without regard to diastolic BP (DBP); however, a 
recent article reported increased mortality in veterans with a DBP ≤ 70 mmHg, and as such, 
the incidence of a DBP ≤ 70 mmHg was determined in our veterans with and without SCI.
(21) The American Autonomic Society (AAS) and the American Academy of Neurology 
(AAN) have defined orthostatic hypotension (OH) as a fall in SBP of ≥ 20 mmHg and/or a 
fall in diastolic BP (DBP) ≥ 10 mmHg.(25-28) Individuals were classified as having OH if 
the change in either SBP or DBP met the AAS and AAN definition within the first 3 minutes 
of assuming an upright position. In addition, participants were categorized as being 
hypertensive (HTN) if their average SBP in either the supine or upright positions was ≥ 140 
and/or their average diastolic BP (DBP) was ≥ 90 mmHg. The observed HR and BP 
recordings were averaged across the available number of values (maximum 6) and 
participants were classified according to their average HR and BP in each of the two 
orthostatic positions.
Data Analysis
Data were analyzed using SPSS version 21. For purposes of data analysis, veterans with SCI 
were categorized by the neurological level of lesion with specific reference to sympathetic 
cardiovascular innervation (SCI status); tetraplegia (tetra: C3-C8), high thoracic (T1-T5) or 
low thoracic (T7-L2) lesions. Differences among the groups for subject characteristics and 
baseline hemodynamics were tested using one-way analysis of variance models. Statistical 
significance for the ANOVA models was set at the p<0.05 level, and were adjusted for 
multiple comparisons with Tukey HSD. To statistically assess the effect of group 
categorization, the data were analyzed using binary logistic regression with presence or 
absence of the specific condition (separate analyses for CA, HYPO, OH & HTN) coded as 
the dependent variable. Pairwise group differences for these prevalence rates were compared 
using univariate chi-square analyses. From the resulting logit calculations, prevalence rates 
(in percentages) were calculated. In addition, following significant omnibus effects in the 
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logistic regression analyses, 95% confidence intervals (CI) were constructed about the 
respective prevalence rates for each group,(29) and pairwise differences between groups for 
prevalence rates were assessed using confidence intervals, as previously described.(30) 
Finally, we entered covariates into the significant logistic regression models to determine if 
the contribution of these variables added to the prediction model. The covariates included: 
chronological age, smoking status (Y, N), number of cardiovascular diagnoses, HTN 
diagnosis (Y, N), and use (Y, N) and number of prescribed anti-HTN medications. For the 
SCI group alone we also entered injury specific demographics as covariates into the binary 
models, including: duration of injury (years) and motor complete (AIS A & B) versus 
incomplete (AIS C & D) lesions.
RESULTS
Two-hundred forty two subjects signed consent to participant, of which 62 veterans with 
SCI and 160 veterans without SCI completed all study procedures; 15 subjects did not 
complete testing and 5 were non-veterans. The study population consisted of predominantly 
male veterans (97%) and ranged in age from 21-88 years. Characteristics of the study groups 
are presented (Table 1); the high thoracic group was significantly younger than the tetra 
group and body mass (kg) was significantly reduced in the high thoracic compared to the 
other 3 groups. The duration of injury in our veterans with SCI ranged from 1 to 54 years 
and 60% of the SCI study group sustained a complete motor injury (AIS A & B). Duration 
of injury and AIS classification were entered into the logistic regression models for the SCI 
groups; however, neither variable contributed to the prediction of the cardiovascular 
abnormalities beyond that explained by SCI status alone.
Resting supine and upright hemodynamics are presented (Figures 1-3). These data show 
that, regardless of orthostatic position, resting HR was significantly reduced in the tetra 
group compared to the other 3 groups (Figure 1). Although supine SBP did not differ among 
the study groups (Figure 2A), upright SBP was reduced in the tetra group compared to the 
non-SCI and low thoracic groups (Figure 2B). In the non-SCI veterans, supine DBP was 
significantly increased compared to the 3 SCI groups (Figure 3A) and upright DBP was 
increased compared to the tetra and low thoracic groups (Figure 3B). Of note, average HR 
was ≥ 80 bpm while upright in the non-SCI veterans and regardless of orthostatic position in 
veterans with high thoracic lesions. Further, average DBP was ≤ 70 mmHg while supine in 
the high thoracic group and regardless of orthostatic position in the tetra group.
Prevalence rates for medical history which is related to the most prevalent cardiovascular 
conditions is presented (Table 2). Current smoking status did not differ among the study 
groups. However, overall omnibus effects were significant for cardiovascular diagnoses, 
HTN diagnosis alone and the use of anti-HTN medications. The diagnosis of CVD, which 
included HTN, diabetes mellitus, high cholesterol, lipids, triglycerides, heart or vascular 
disease, was lower in high thoracic compared to the other 3 groups; however, this group 
effect was eliminated with addition of chronological age. The diagnosis of HTN alone was 
reduced in veterans with high thoracic and cervical lesions compared to the non-SCI and 
low thoracic veteran groups, use of prescription anti-HTN medications was increased in the 
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low thoracic group compared to the other 3 groups, and was increased in the non-SCI 
compared to the tetra group.
The probability and omnibus χ2 effects for HR and BP abnormalities relative to group 
affiliation is presented (Table 3). Prevalence rates for HTN and OH did not differ among the 
study groups. However, the omnibus tests from the binary logistic regression analyses for 
group differences were statistically significant for CA, systolic and diastolic HYPO. The 
prevalence of CA was reduced in the tetra group compared to the other 3 groups. The 
prevalence of systolic HYPO was increased in the tetra group compared to the other three 
groups, and the prevalence of diastolic HYPO was reduced in non-SCI veterans compared to 
the 3 groups of veterans with SCI.
To examine the influence of the aforementioned covariates, additional logistic regression 
models were constructed with the individual covariates included in the models (Table 4). 
For all analyses, the covariates were not significant with the exception of age and number of 
anti-HTN medications in the CA model; however, even with these covariates included in the 
model, “group” was still a significant predictor of CA (p < 0.01).
DISCUSSION
In this investigation we sought to determine prevalence rates for HR and BP abnormalities 
in veterans with SCI compared to a veteran cohort without SCI. The data suggest that SCI 
status, but not AIS classification or duration of injury, contributes to the prevalence of CA, 
systolic and diastolic HYPO. In addition, SCI status contributed to the reduced prevalence of 
the diagnosis of HTN and the use of anti-HTN medications in those with higher cord 
lesions. Although our data suggest that the prevalence of OH, systolic and diastolic HTN did 
not differ significantly among the groups, regardless of SCI status, the diagnosis of HTN 
was increased in the non-SCI and low thoracic veteran groups compared to veterans with 
high cord lesions (above T6).
We have noted increased resting HR in individuals with paraplegia compared to individuals 
with tetraplegia and non-SCI controls in laboratory observations (31, 32) as well as over the 
course of a typical 24-hour day. (33) The present data suggest that more than 50% of 
veterans with high and low thoracic lesions and those without SCI have a resting HR above 
80 bpm. The reported consequences of persistently elevated HR include increased 
cardiovascular morbidity, (34) atherosclerosis and cardiovascular mortality, (22, 35) 
hypertension, (36) and accelerated progression of arterial stiffness, (16) and, as such, 
persistently elevated HR constitutes an emerging cardiovascular risk factor. (15) The 
relevance of applying these findings derived from studies performed in the general 
population to persons with SCI has not yet been established. However, CVD is a leading 
cause of mortality in the SCI population, (37) increased diagnosis of HTN has been reported 
in veterans with paraplegia compared to veterans with tetraplegia, (38) and increased arterial 
stiffness is reported among individuals with SCI compared to matched non-SCI controls. 
(39-41) Furthermore, similar to prior reports (38, 42) the present data suggest that nearly 
three-quarters of the low thoracic population carry the diagnosis of HTN, whereas the 
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significantly reduced prevalence of HTN found in our high thoracic group was fully 
accounted for by age.
Increased prevalence of systolic HYPO in the tetra and high thoracic groups was not 
surprising and can be attributed to decentralized sympathetic outflow to the vasculature. (12, 
13, 43) An unexpected finding was that the prevalence of systolic HYPO was doubled in 
veterans with low thoracic lesions compared to veterans without SCI and was comparable to 
the high thoracic group. Level of lesion in the low thoracic group ranged from T7-L1 and 
systolic HYPO was predominantly in those with lesions at or above T10, in whom 
sympathetic control of the splanchnic vascular bed would likely be partially decentralized. 
Although we found relatively increased use of prescription anti-HTN medications in 
veterans with low thoracic lesions, this incidence rate did not contribute to the prevalence of 
systolic HYPO in this group. There is a growing body of literature which suggests that 
persistently low systolic BP is associated with cognitive dysfunction (18, 44-46) and mood 
disorders. (17, 20, 47) We demonstrated that hypotensive individuals with SCI perform 
more poorly on tasks of memory and attention processing compared to matched (for 
incidence of traumatic brain injury) normotensive individuals with SCI. (48) In addition, we 
reported that individuals with SCI, as well as their clinical care providers, were able to 
ascribe adverse health-related quality of life effects, which stem from persistent 
hypotension. (49) However, because most individuals with persistently low systolic BP 
remain asymptomatic, treatment is very rare, and in fact, the present data indicate that 
although nearly one-third of the SCI population studied had systolic HYPO only 3 patients 
(1 high thoracic and 2 tetra) were prescribed an anti-HYPO medication.
In addition to systolic HYPO, more than 50% of the SCI population had diastolic HYPO, 
defined as a DBP ≤ 70 mmHg, regardless of level, AIS classification, or duration of injury; 
whereas the prevalence of diastolic HYPO was 30% in the non-SCI veterans. A recent study 
conducted in a large veteran population (n=14,270) documented, via retrospective chart 
review, increased all-cause mortality after adjusting for comorbidities in veterans with a 
DBP ≤ 70 mmHg.(21) These investigators reported a higher incidence of diastolic HYPO in 
their population (49%) compared to our findings in the non-SCI veterans; however their 
veterans with diastolic HYPO were nearly a decade older (68±9 years) than our non-SCI 
veterans with diastolic HYPO (59±14 years).(21) Moreover, the prevalence of a diastolic 
HYPO was increased in all three SCI groups studied (56%) compared to both groups of non-
SCI veterans, and the mean age of the diastolic HYPO group among veterans with SCI was 
58±14 years. The mortality risk associated with diastolic HYPO in individuals with SCI is 
not known, but age, cardiovascular diagnoses and prescription anti-HTN medications did not 
account for group differences in this prevalence rate.
Interestingly, the prevalence of OH did not differ significantly among our study groups, and 
ranged between 22% (high thoracic) and 36% (tetra). Age did not contribute to the 
prevalence of OH in our study population; however, the prevalence rate of OH appears to be 
higher than previously reported in otherwise healthy middle-aged males (12%), (50) 
regardless of SCI status. This has significant clinical implication because OH is associated 
with increased morbidity and mortality in otherwise healthy asymptomatic individuals (i.e., 
those that do not complain of dizziness, lightheadedness, nausea, blurred vision, etc.).
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(51-58) It should be noted that we reported BP from manual sphymomanometry at the 
brachial artery; however, a recent report suggests markedly higher prevalence rates for OH 
using beat-to-beat BP recordings in men 65+ years old.(59)
We hypothesized that, due to impaired sympathetic vasomotor tone, veterans with high cord 
lesion (above T6) would have a relatively low incidence of the diagnosis of HTN compared 
to veterans with low cord lesions (T7 and below) and those without SCI. The data support 
our hypothesis in that the diagnosis of CVD in general, and HTN in particular, was reduced, 
and as a result use of prescription anti-HTN medications was lower, in veterans with spinal 
cord lesions above T6. A recent paper documented, through medical chart review, the 
prevalence of HTN diagnosis in veterans without SCI as 68.4% compared to a prevalence of 
56.6% in veterans with SCI. (38) We found a similar prevalence of the diagnosis of HTN in 
our non-SCI veterans, but due to our differentiation of level of injury relative to the origin of 
sympathetic vasomotor control, our findings in veterans with SCI differ from those reported 
by Barry et al. (38) Specifically, the incidence of the diagnosis of HTN was higher in our 
veterans with SCI below T7 (72.7%), but the incidence was significantly lower in those with 
lesions above T6 (≈22%). It is therefore important to consider level of injury relative to 
peripheral sympathetic vasomotor control when reporting the incidence of HTN in persons 
with SCI.
Of interest, two-thirds of the veterans with tetraplegia studied carried the diagnosis of 
diabetes mellitus, which may have clinical relevance. Twenty years ago our group reported 
abnormalities in carbohydrate and lipid metabolism in 67% of veterans with tetraplegia (age: 
47±2 years) residing in the New York City metropolitan area.(60) In a second publication 
we reported that 23% of subjects with complete tetraplegia (age: 38±1 years) were diabetic. 
(61) It should be appreciated that the incidence of DM increases with advancing age, (60) 
and today, 90% of our veterans with tetraplegia are older than 50; 57% are older than 60.
Study Limitations
A limitation of this study is that there was no assessment of autonomic dysreflexia (AD) in 
veterans with SCI. The definition of AD includes an increase in BP ≥ 20/10 mmHg, which 
may be associated with symptoms including pounding headache, profuse sweating and 
piloerection above lesion.(62) We were unable to assess the prevalence of AD, which stems 
from an unrestrained outpouring of norepinephrine from the post-synaptic sympathetic 
ganglia due to noxious or non-noxious stimuli below the level of lesion, because our data 
were collected in a resting state. However, elevation in resting BP, which we attributed to 
HTN, may reflect AD, particularly in individuals with high cord lesions. Large variability in 
BP is a concern in the SCI population, and because our data were calculated from average 
BP recordings during a single clinical visit, we may have underestimated the prevalence 
rates of BP and HR abnormalities and we recognize that these data may not adequately 
reflect overall cardiovascular hemodynamics in our veterans. It should be noted that the 
groups were recruited from a convenience sample of veterans with and without SCI, and 
were not matched for demographic data or medical history; therefore group comparisons 
should be interpreted with caution and extrapolation to the general VA may be 
inappropriate. In addition, comparisons for the prevalence of cardiovascular diagnoses, 
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medications and cardiovascular abnormalities in the group with high thoracic lesions should 
be interpreted with caution because of the small sample size and the lower chronological age 
compared to the other groups. Also, because a greater percentage of veterans without SCI 
and those with low thoracic lesions were prescribed anti-HTN medications than veterans 
with high thoracic and cervical lesions, the use of these agents may have served to bias the 
analyses. Finally, it should be noted that there were too few women in our study population 
to discern any unique characteristics of gender on prevalence rates for the hemodynamic 
abnormalities documented.
In conclusion, our data support the notion that SCI status conveys appreciable 
cardiovascular risk for increased prevalence of CA, systolic and diastolic HYPO. In 
addition, prevalence of OH appears to be increased in our veterans with and without SCI at 
an earlier age than previously reported. Because cardiac acceleration and persistent and 
episodic hypotension are associated with adverse cognitive and mood consequences, as well 
as increased morbidity and mortality in the general population, the increased prevalence of 
these conditions in the SCI population should be considered a priority for clinical 
investigations and in the management of the health and wellbeing of these individuals. 
These findings provide a foundation for the development of a national registry describing 
cardiovascular parameters in the veteran population.
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Box plot demonstrating the mean, max and min resting Heart Rate (HR: bpm) in the supine 
[A] and upright [B] positions among non-SCI veterans (open bar) and veterans with low 
thoracic (LT: dark gray bars), high thoracic (HT: hatched bars) and cervical lesions (T: light 
gray bars). * p<0.05; ** p<0.01; *** p<0.001 versus the Tetra group.
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Box plot demonstrating the mean, max and min resting Systolic Blood Pressure (SBP: 
mmHg) in the supine [A] and upright [B] positions among non-SCI veterans (open bar) and 
veterans with low thoracic (LT: dark gray bars), high thoracic (HT: hatched bars) and 
cervical lesions (T: light gray bars). ** p<0.01; *** p<0.001 versus the Tetra group.
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Box plot demonstrating the mean, max and min resting Diastolic Blood Pressure (DBP: 
mmHg) in the supine [A] and upright [B] positions among non-SCI veterans (open bar) and 
veterans with low thoracic (LT: dark gray bars), high thoracic (HT: hatched bars) and 
cervical lesions (T: light gray bars). *** p<0.001 versus the Tetra group; δ p<0.05 versus the 
non-SCI group.
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Age (y) 57±11 57±10 48±20 60±11*
Age range (y) 21-88 32-73 22-83 37-79
HT (m) 1.78±0.08 1.78±0.06 1.78±0.07 1.76±0.33
WT (kg) 88±18 88±30 64±27*** 86±26
BMI (kg/m2) 28.5±5.7 29.0±7.1 23.0±4.0 27.4±6.2
Female Gender (n) 3 1 1 1
Duration (y) NA 21±13 18±18 20±14
Level of SCI NA T7-L2 T1-T5 C3-C8
AIS A NA 12 (55%) 6 (67%) 11 (36%)
AIS B NA 2 (9%) 1 (11%) 5 (16%)
AIS C NA 5 (23%) 1 (11%) 9 (29%)
AIS D NA 3 (14%) 1 (11%) 6 (19%)




p<0.01 versus HP group:
***
p<0.000 versus all other groups:





















Thoracic Tetra χ 
2 p value
Current Smokers 30.0% 31.8% 11.1% 25.8% 1.991 0.574
Cardiovascular Diseases Diagnoses 70.6% 72.7% 22.2% 64.5% 8.877 0.031
HTN Diagnosis 66.9% 72.7% 22.2% 22.6% 28.109 0.000
Diabetes Mellitus 26.3% 31.2% 11.1% 67.7% 2.090 0.554
High Cholesterol, Lipids, Triglycerides 31.9% 45.4% 22.2% 38.7% 2.451 0.484
Heart & Vascular Disease 12.5% 9.1% 0.0% 12.9% 2.535 0.459
anti-HTN Medications 65.6% 81.8% 44.5% 41.9% 11.117 0.011
α1:-blockers 14.4% 9.1% 11.1% 6.5% 1.994 0.574
β-blockers 20.0% 31.8% 33.3% 16.1% 2.700 0.440
Calcium Channel-blockers 25.0% 31.8% 0.0% 3.2% 15.498 0.001
ACE and ARBs 39.4% 59.1% 11.1% 22.6% 10.799 0.013
Nitrates 3.8% 4.6% 0.0% 6.5% 1.188 0.756
Diuretics 37.5% 22.7% 0.0% 9.7% 18.560 0.000
anti-HYPO Medications 0.0% 0.0% 11.1% 6.5% 10.673 0.014
α-agonists 0.0% 0.0% 11.1% 3.2% 1.994 0.574
Mineralocorticoids 0.0% 0.0% 0.0% 3.2% 3.965 0.265





















Thoracic Tetra χ 
2 p value
Cardiac Acceleration (≥ 80 bpm) 56.2% 54.5% 66.7% 16.1% 19.219 0.000
Systolic Hypotension (≤ 110 mmHg) 13.7% 22.7% 22.2% 38.7% 9.794 0.020
Diastolic Hypotension (≤ 70 mmHg) 30.0% 54.5% 66.8% 67.8% 21.061 0.000
OH (≥−20/10 mmHg fall) 24.4% 22.7% 22.2% 35.5% 1.761 0.623
Systolic Hypertension (≥ 140 mmHg) 41.9% 45.5% 22.2% 32.3% 2.579 0.461
Diastolic Hypertension (≥ 90 mmHg) 18.1% 4.5% 22.2% 9.7% 4.646 0.200
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Table 4
A: Significant Multiple Regression Results
CA systolic HYPO diastolic HYPO





Constant 1.775 0.791 0.025 −2.674 0.973 0.006 −1.42 0.774 0.067
Group dummy code X1 −2.392 0.690 0.001 0.761 0.523 0.146 1.345 0.486 0.006
Group dummy code X2 0.250 0.790 0.752 0.370 0.894 0.679 1.681 0.770 0.029
Group dummy code X3 −0.101 0.474 0.830 0.661 0.573 0.249 1.115 0.474 0.019
age (years) −0.030 0.014 0.039 0.021 0.017 0.213 0.011 0.014 0.417
smoking (y/n) −0.102 0.325 0.754 0.070 0.403 0.861 0.337 0.326 0.302
CVD diag (y/n) 1.238 0.751 0.099 0.485 0.627 0.440 0.379 0.614 0.537
HTN diag (y/n) −0.477 0.860 0.579 −1.440 0.792 0.069 −0.988 0.745 0.185
anti-HTN meds (y/n) 0.679 0.625 0.278 0.418 0.680 0.539 −0.330 0.610 0.588
anti-HTN meds (#) −0.539 0.193 0.005 −0.086 0.253 0.735 0.284 0.177 0.110
B: Non-significant Mutiple Regression Results
OH systolic HTN diastolic HTN





Constant −1.536 0.857 0.073 −0.787 0.79 0.319 −0.89 0.997 0.372
Group dummy code X1 0.497 0.529 0.347 0.016 0.520 0.975 −0.731 0.843 0.386
Group dummy code X2 0.045 0.895 0.960 −0.256 0.898 0.776 0.374 0.936 0.689
Group dummy code X3 −0.221 0.558 0.693 0.153 0.488 0.755 −1.660 1.052 0.115
age(years) −0.006 0.015 0.673 −0.013 0.014 0.373 −0.031 0.018 0.081
smoking (y/n) 0.593 0.343 0.084 −0.106 0.329 0.748 0.005 0.429 0.990
CVD diag (y/n) 0.580 0.661 0.380 1.031 0.640 0.107 1.127 0.916 0.219
HTN diag (y/n) −1.213 0.803 0.131 0.542 0.741 0.464 −0.785 1.045 0.453
anti-HTN meds (y/n) 0.879 0.648 0.175 −0.584 0.631 0.355 0.953 0.837 0.255
anti-HTN meds (#) 0.245 0.183 0.179 −0.787 0.790 0.319 −0.890 0.997 0.372
Constant=non-SCI; X1=Tetra [1,0,0]; X2=High Thoracic [0,1,0]; X3=Low Thoracic [0,0,1]
CVD diag (y/n)=yes/no cardiovascular disease diagnoses; HTN diag (y/n)= yes/no diagnosis of hypertension
anti-HTN meds (y/n)= yes/no prescribed anti-hypertensive agents; anti-HTN meds (#)=number of prescribed anti-hypertensive agents
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